91892-39-6

Basic information

• Product Name: N2,N2,N6,N6-tetramethyl-N4-[(4-nitrophenyl)methylideneamino]-1,3,5-tri azine-2,4,6-triamine
• Synonyms: N2,N2,N6,N6-tetramethyl-N4-[(4-nitrophenyl)methylideneamino]-1,3,5-tri azine-2,4,6-triamine
• CAS NO: 91892-39-6
• Molecular Formula: C₁₄H₁₈N₈O₂
• Molecular Weight: 0
• Mol File: 91892-39-6.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 534.3°Cat760mmHg
• Flash Point: 276.9°C
• Appearance: /
• Density: 1.33g/cm³
• CAS DataBase Reference: N2,N2,N6,N6-tetramethyl-N4-[(4-nitrophenyl)methylideneamino]-1,3,5-tri azine-2,4,6-triamine(CAS DataBase Reference)
• NIST Chemistry Reference: N2,N2,N6,N6-tetramethyl-N4-[(4-nitrophenyl)methylideneamino]-1,3,5-tri azine-2,4,6-triamine(91892-39-6)
• EPA Substance Registry System: N2,N2,N6,N6-tetramethyl-N4-[(4-nitrophenyl)methylideneamino]-1,3,5-tri azine-2,4,6-triamine(91892-39-6)

Safety Data

• Hazardous Substances Data: 91892-39-6(Hazardous Substances Data)

Upstream product

• 555-16-8 4-nitrobenzaldehdye 
• 10409-78-6 N²,N²,N⁴,N⁴-tetramethyl-2,4-diamino-6-hydrazinyl-[1,3,5]triazine 

Downstream Products

• 91892-57-8 5,7-bis(dimethylamino)-2-(4-nitrophenyl)<1,2,4>triazolo<1,5-a><1,3,5>triazine 
• 91892-48-7 5,7-bis(dimethylamino)-3-(4-nitrophenyl)-1,2,4-triazolo<4,3-a><1,3,5>triazine 

Relevant articles and documents

Triazines and Related Products. Part 26. Synthesis and Chemistry of Bicyclic Analogues of the Antitumour Drug 2,4,6-Tris(dimethylamino)-1,3,5-triazine (Hexamethylmelamine)

Interaction of 2,4-bis(dimethylamino)-6-hydrazino-1,3,5-triazine (1c) with aryl aldehydes yields a series of aryl hydrazones (4) which cyclise to 3-aryl-5,7-bis(dimethylamino)-1,2,4-triazolotriazines (6) with lead(VI) acetate in dichloromethane.Rearrangement of these bicycles in methanolic sodium hydroxide affords stable isomeric 2-aryl-5,7-bis(dimethylamino)triazolotriazines (7).Selected examples from both series of triazolotriazines were screened against the mouse M5076 reticulum cell sarcoma and P388 leukaemia in vivo but proved to have no antitumour activity.